U/PIPELINE

Pipeline & Trials

4 filings logged

Clinical-stage assets and trial readouts — Phase I to registration, endpoints, outcomes and pipeline strategy.

Unit log

  1. K-5091

    ImmunoBrain's Anti-PD-L1 Antibody Cuts Alzheimer's Damage Biomarkers in Phase Ib

  2. P-2627

    NIH to replace disease-based trial funding with five trial-type NOFOs

  3. V-7932

    Glenmark files US FDA IND for three-target oncology drug ISB 2301